Immunohistochemistry Staining

Specificity comes from the primary antibody’s binding to its target antigen in the tissue section. The labeled secondary antibody then recognizes the primary antibody and produces either an enzyme-linked color reaction or a fluorescent signal. Because the signal is tied to antibody binding, its location can be interpreted alongside the preserved tissue architecture, helping relate protein identity to particular cells or regions.

Both systems convert antibody binding into an observable result, but they do so in different formats. Enzyme-linked systems generate a visible color, whereas fluorescent secondary antibodies produce a fluorescent signal. This distinction affects how the protein distribution is visualized and recorded, while the underlying strategy remains the same: use labeled detection after the primary antibody has bound its antigen.

Preserved architecture provides the spatial framework needed to interpret a protein signal. Rather than reporting only that a target is present, immunohistochemistry staining shows where it occurs within an organized tissue section. That spatial information supports comparisons among cell types, tissue regions, and patterns of organization, making molecular findings more meaningful in biological and disease-related studies.

Cell types can be distinguished by comparing the location and distribution of target proteins across the tissue. A signal concentrated in particular cells or regions provides a molecular marker that can be related to visible tissue organization. This approach is especially useful when researchers need to connect protein expression with cellular identity rather than examine tissue structure alone.

Work begins with a preserved tissue section and application of a primary antibody selected for the antigen of interest. After that antibody binds, a labeled secondary antibody provides detection through color or fluorescence. The resulting signal is examined in the context of the section’s cellular and tissue structure, allowing researchers to map the target protein and compare its distribution.

Researchers choose the method when the location of a protein matters as much as its presence. In pathology and cancer research, staining can reveal biomarker distribution and differences among tissue regions. In neuroscience and other experimental biology studies, it can map proteins within organized tissues. These observations help relate molecular changes to cell types, tissue organization, development, or disease.

Interpretation focuses on the signal’s location and distribution across the preserved section. Researchers can ask whether a biomarker appears in particular cell types, tissue regions, or organizational patterns, and whether that pattern differs in development or disease. The result is a spatial comparison of protein expression, not simply a yes-or-no measurement of whether the protein exists.